AstraZeneca's Airsupra (albuterol/budesonide) met the primary endpoint in the Phase III BATURA trial, significantly reducing ...

BeiGene has launched Tevimbra (tislelizumab) in the USA for treating adults with esophageal squamous cell carcinoma (ESCC) ...

US healthcare giant Johnson & Johnson (NYSE: JNJ) revealed it is discontinuing the Phase II field study (NCT05201794) ...

Kezar Life Sciences has paused its Phase IIb PALIZADE trial for zetomipzomib in lupus nephritis after four patient deaths, ...

The Irish Healthcare Association (IPHA), the representative body for the research-based biopharmaceutical industry in ...

ViroCell Biologics, a UK contract development and manufacturing organization (CDMO), has announces the appointment of ...

India's new Biotechnology Research Innovation and Entrepreneurship Development (Bio-RIDE) scheme is a significant step ...

US pharma giant Pfizer (NYSE: PFE) has announced that John McGinley has been appointed UK managing director and country ...

Important regulatory news last week included French pharma major Sanofi gaining approval from the US Food and Drug ...